NCT05804617

Dome-type (Modified C-incision) Manual Morcellation During Laparoscopic Uterine Surgery

Dome-type (Modified C-incision) Extracorporeal Manual Morcellation During Laparoscopic Uterine Surgery: A Retrospective Analysis
National Taiwan University Hospital·ClinicalTrials.gov·procedureCompleted
View on ClinicalTrials.gov
Study focus
Drug/Device/Intervention
Dome-type (Modified C-incision) manual morcellation
Study type
Interventional
Intervention type
procedure
Sponsor & location
Primary sponsor
National Taiwan University Hospital
Location
Taipei, Taiwan
Timeline & enrollment
Phase
N/A
Start date
May 20, 2020
End date
Sep 01, 2022
Enrollment
41 participants
Primary outcome

Morcellation speed

Summary

In-bag manual morcellation is a safe alternative procedure after FDA's discouragement of
 electronic power morcellator. The traditional wedging (V-type incision) or semicircular
 coring (C-type incision or ExCITE) method are the most common morcellation techniques. For
 beginners, it is somehow not that easy to get familiar with these methods. No teaching or
 learning experiences were reported. Therefore, we developed a dome-type (modified C-incision)
 technique to manually morcellate uteri leiomyoma or uterus at the time of laparoscopic
 surgery and report perioperative outcomes and the learning experiences of our residents for
 this technique from our two years of experience.

ICD-10 classifications
Surgical procedure, unspecifiedMedical procedure, unspecifiedOther surgical proceduresDuring unspecified surgical and medical careDuring unspecified surgical and medical care
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05804617
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05804617 through Pure Global AI's free database. This phase not specified trial is sponsored by National Taiwan University Hospital and is currently Completed. The study focuses on Surgical Procedure, Unspecified. Target enrollment is 41 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.